The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Scientific and Medical of Aspects: Human Reproductive Cloning
response to the midcycle surge of luteinizing hormone thus introducing a delay that seems to make blastocyst formation more likely). He also made clones of a clone in mice.
Panayiotis Michael Zavos is a professor emeritus of reproductive physiology-andrology at the University of Kentucky; founder, director, and chief andrologist of the Andrology Institute of America; cofounder and codirector of the Kentucky Center for Reproductive Medicine and IVF; and president and CEO of ZDL, Inc., a private corporation that markets infertility products and technologies worldwide. He received a BS in biology and chemistry in 1970, an MS in biology and physiology in 1972, and an EdS in 1976 from Emporia State University, in Kansas. Dr. Zavos received his PhD in reproductive physiology and statistics in 1978 from the University of Minnesota in Twin Cities.